Epithelial Cell Culture Media Market Growth Drivers and Forecast by 2028

The epithelial cell culture media market is expected to reach US$ 303,040.33 thousand by 2028 from US$ 128,155.95 thousand in 2020; it is estimated to grow at a CAGR of 11.4% from 2021 to 2028.

Epithelial cells are widespread throughout the body. These cells cover body surfaces, line body cavities, hollow organs, and major tissues in glands. These cells perform functions such as protection, absorption, secretion, excretion, diffusion, filtration, and sensory reception. These cells are widely used in disease modeling, toxicity studies, and drug discovery, among other applications. The growth of the epithelial cell culture media market is attributed to the factors such as the increasing applications of epithelial cells and surge in funding for epithelial cell research. However, the risk of contamination, misidentification, and random alternations in cell lines hinders the market growth.  

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

Epithelial Cell Culture Media Market: Strategic Insights

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

Market Insights

Surge in Funding for Epithelial Cell Research

Extensive funding for supporting the research projects involving the use of epithelial cells to identify new therapeutic solutions for chronic diseases is propelling the demand for epithelial cell culture media. For instance, the National Institutes of Health (NIH), US, funded a 3-year research project (2013–2016) that was conducted at the University of Kentucky. The institute granted US$ 307,395 in funds in 2014 to examine processes controlling inflammation in colitis, a condition that stimulates epithelial stem cell growth and differentiation and increases the risk of colon cancer.

In 2018, scientists at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research along with those at the Stein Eye Institute were granted US$ 5.1 million by the California Institute for Regenerative Medicine to advance the development of a novel therapy for blinding retinal conditions. The project setup includes the use of patients’ own skin cells to generate autologous induced pluripotent stem cells to derive retinal pigment epithelium cells that are lost in blinding eye conditions.

Further, the Osaka University, Japan, conducted a research study—Observation of the Epithelial Cell Behavior in the Nasal Septum During Primary Palate Closure in Mice. This study was supported by Grants-In-Aid for Scientific Research Program of the Japan Society for the Promotion of Science. The increase in such grants for epithelial cell-based research projects are favoring the epithelial cells culture market growth.

Product Type-Based Insights

By product type, the epithelial cell culture media market is segmented into human mammary epithelial cells, bronchia/trachea epithelial cells, and renal epithelial cells. The bronchia/trachea epithelial cells segment held the largest share of the market in 2020, whereas the renal epithelial cell segment is anticipated to register the highest CAGR in the market during the forecast period.

End User-based Insights

Based on end user, the epithelial cell culture media treatment market is segmented into biopharmaceutical companies, academic and research laboratories, and others. The biopharmaceutical companies segment held the largest share of the market in 2020, whereas the academic and research laboratories segment is anticipated to register the highest CAGR of in the market during the forecast period.

Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the epithelial cell culture media market players focus on the collaboration strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name globally.

Epithelial Cell Culture Media Market Regional Insights

The regional trends and factors influencing the Epithelial Cell Culture Media Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Epithelial Cell Culture Media Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Epithelial Cell Culture Media Market Report Scope

Epithelial Cell Culture Media Market Players Density: Understanding Its Impact on Business Dynamics

The Epithelial Cell Culture Media Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Epithelial Cell Culture Media Market – by Product Type

• Human Mammary Epithelial Cells
• Bronchia/Trachea Epithelial Cells
• Renal Epithelial Cells
• Others

Epithelial Cell Culture Media Market – by End User

• Biopharmaceutical Companies
• Academic and Research Laboratories
• Others

Epithelial Cell Culture Media Market – by Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • Italy
  • UK
  • Spain
  • Rest of Europe
• Asia Pacific (APAC)
  • China
  • India
  • South Korea
  • Japan
  • Australia
  • Rest of Asia Pacific
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
• South and Central America (SCAM)
  • Brazil
  • Argentina
  • Rest of South and Central America

Company Profiles

• PromoCell GmbH
• Merck KGaA
• ATCC
• AXOL Bioscience Ltd.
• Thermo Fisher Scientific Inc.
• Bio-Techne Corporation
• Celprogen Inc.
• Lonza Group AG
• HiMedia Laboratories
• Cell Biologics Inc